- Conditions
- ER+ Breast Cancer, HER2-negative Breast Cancer
- Locations
-
- Institut de Cancérologie de l'Ouest Angers, France
- Centre Hospitalier Annecy Genevois_Site d'Annecy Annecy, France
- Institut du Cancer Avignon Sainte Catherine Avignon, France
- Centre Hospitalier Simone Veil de Blois Blois, France
Clinical trial condition
ER+ Breast Cancer
Explore clinical trials studying ER+ Breast Cancer. Study availability and eligibility vary by location and protocol.
22 public trials
11 recruiting studies
ER+ Breast Cancer trial results
Not Yet Recruiting
Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.
NCT07443774
- Conditions
- Abemaciclib, Breast Cancer, Breast Diseases, +9 more
- Locations
-
- CHU Grenoble Alpes Grenoble, France
Not Yet Recruiting
Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer
NCT06407401
- Conditions
- Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, +17 more
- Locations
-
Not specified
Completed
Alcohol and Breast Cancer (ABC) Trial
NCT05423730
- Conditions
- Aromatase Inhibitors, Breast Cancer, Breast Diseases, +6 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT00828854
- Conditions
- Breast Diseases, Breast Neoplasms, ER+ Breast Cancer, +4 more
- Locations
-
- St. Vincent's University Hospital Dublin, Ireland
- The University of Birmingham Birmingham, United Kingdom
- Velindre Hospital - Whitchurch Cardiff, United Kingdom
- Whiston Hospital; Clatterbridge Centre for Oncology Liverpool, United Kingdom
NCT00676663
- Conditions
- Animal Diseases, Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, +9 more
- Locations
-
- California Cancer Care Greenbrae, California, United States
- Moores UCSD Cancer Center La Jolla, California, United States
- Scripps Health La Jolla, California, United States
- University of Colorado Aurora, Colorado, United States
NCT04312347
- Conditions
- Breast Diseases, Breast Neoplasms, ER+ Breast Cancer, +4 more
- Locations
-
- MRCCC Siloam Hospital Semanggi Jakarta, DKI Jakarta, Indonesia
NCT02580448
- Conditions
- Advanced Breast Cancer, Breast Cancer, Breast Diseases, +12 more
- Locations
-
- Wallace Tumor Institute- University of Alabama Birmingham, Alabama, United States
- Clearview Cancer Institute Huntsville, Alabama, United States
- University of Colorado Aurora, Colorado, United States
- Rocky Mountain Cancer Centers Lakewood, Colorado, United States
NCT01202591
- Conditions
- Breast Diseases, Breast Neoplasms, ER+ Breast Cancer, +5 more
- Locations
-
- Research Site Leuven, Belgium
- Research Site Namur, Belgium
- Research Site Brno, Czechia
- Research Site Prague, Czechia
Active, Not Recruiting
Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression
NCT04920708
- Conditions
- Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Addenbrookes Hospital Cambridge, Cambridgeshire, United Kingdom
- Royal Cornwall Hospital Truro, Cornwall, United Kingdom
- Mount Vernon Cancer Centre London, Surrey, United Kingdom
- Velindre Cancer Centre Cardiff, Wales, United Kingdom